Palvella Therapeutics, Inc. Common Stock (PVLA) is a publicly traded Healthcare sector company. As of September 2, 2026, PVLA trades at $152.71 with a market cap of $2.20B and a P/E ratio of -40.52. PVLA moved +1.75% today. Year to date, PVLA is +50.13%; over the trailing twelve months it is +185.62%. Its 52-week range spans $12.02 to $161.38. Analyst consensus is strong buy with an average price target of $233.20. Rallies surfaces PVLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PVLA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $152.71 |
| Market Cap | $2.20B |
| P/E Ratio | -40.52 |
| EPS | $-3.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $161.38 |
| 52-Week Low | $12.02 |
| Volume | 16.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.59M |
| Net Income | $-41.72M |
| Gross Margin | 0.00% |
10 analysts cover PVLA: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $233.20.